Literature DB >> 9883633

[The coexistence of pulmonary tuberculosis and lung cancer].

T Kurasawa1.   

Abstract

To summarize the clinical features of the coexistence of lung cancer (LC) and pulmonary tuberculosis (TB) from the reports in Japan. The frequency is about 2-4% of LC and about 1-2% of TB and elderly men are frequent. Lung cancer is mainly from periphery origin and squamous cell carcinoma, histopathologically. Cavitary lesions are few of pulmonary tuberculous lesions and those are not occasionally detectable in the pictures. The lesions of LC and TB are mainly located in same lung, and sometimes in same lobe. By the interval of diagnosis of LC and TB, the patients are divided to three groups; TB proceeding type, LC proceeding type and coexistence type. Because of the very high TB infected rate of elder people in Japan, who have also high incidence rate of LC, the rate of coexistence of LC and TB is high, so the patients suffered from either disease are necessary to follow up carefully as the high-risk group of other disease.

Entities:  

Mesh:

Year:  1998        PMID: 9883633

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  4 in total

1.  Differential diagnosis of acute miliary pulmonary tuberculosis from widespread-metastatic cancer for postoperative lung cancer patients: two cases.

Authors:  Wei Zhao; Yuke Tian; Feng Peng; Jianlin Long; Lan Liu; Meijuan Huang; You Lu
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

2.  Coexistence of acute miliary pulmonary tuberculosis and metastatic lung adenocarcinoma: a case report.

Authors:  Yan Wang; Lingli Tu; Zhiping Li; Xin Wang; Yong Luo; Chuying Huang; Lan Sun
Journal:  Quant Imaging Med Surg       Date:  2013-06

3.  MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases.

Authors:  Kyeong-Cheol Shin; Kwan-Ho Lee; Chae-Hun Lee; Im-Hee Shin; Hun-Suk Suh; Chang-Ho Jeon
Journal:  Oncol Rep       Date:  2011-11-29       Impact factor: 3.906

4.  Evaluation of coexistence of cancer and active tuberculosis; 16 case series.

Authors:  Beyhan Çakar; Aydın Çiledağ
Journal:  Respir Med Case Rep       Date:  2017-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.